Skip to main content
    S

    Sanofi ADR (SNY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $48.39
    +0.02 (+0.04%)

    Market Cap: $116.15B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sanofi ADR (SNY) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Sanofi ADR (SNY) trades at 2.0x sales and 1.4x book value. Its P/S of 2.0x is below its 5-year median of 2.6x.

    Current Multiples

    SNY reports in EUR, so earnings multiples appear here only when its per-share earnings can be confirmed.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales2.0x
    Price to book1.4x
    EV/EBITDA7.3x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 25.9% below 2.7x and its P/B is 12.5% below 1.6x.

    MultipleCurrent5-year median10-year median
    P/S2.0x2.6x2.7x
    P/B1.4x1.5x1.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 2.2x in 2025 to 3.0x in 2019. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$48.462.2x1.4x
    2024$48.232.6x1.5x
    2023$49.732.5x1.5x
    2022$48.432.6x1.5x
    2021$50.102.8x1.6x
    2020$48.592.8x1.6x
    2019$50.203.0x1.9x
    2018$43.412.6x1.6x
    2017$43.002.6x1.5x
    2016$40.442.7x1.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    P/E history is shown only for companies that report in US dollars.

    Frequently Asked Questions About SNY

    What is SNY's price to sales ratio?

    Sanofi ADR has a price to sales ratio of 2.0x.